A Phase I/IB Study of OSI-906 and Irinotecan in Patients With Advanced Cancer With Expanded Cohorts of Patients With Colorectal Cancer Stratified by the OSI-906 Integrated Classifier

Trial Profile

A Phase I/IB Study of OSI-906 and Irinotecan in Patients With Advanced Cancer With Expanded Cohorts of Patients With Colorectal Cancer Stratified by the OSI-906 Integrated Classifier

Discontinued
Phase of Trial: Phase I

Latest Information Update: 18 Oct 2013

At a glance

  • Drugs Linsitinib (Primary) ; Irinotecan
  • Indications Cancer; Colorectal cancer
  • Focus Adverse reactions; Pharmacokinetics; Registrational; Therapeutic Use
  • Most Recent Events

    • 18 Oct 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Jan 2013 Planned End Date changed from 1 Dec 2011 to 1 Dec 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top